Clinical Trials Browser

OTHER_GOV × Carcinoma, Hepatocellular × tislelizumab × Clear all

NCT05897138 2023-06-13

A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05407519 2023-03-22

A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05545124 2022-09-19

Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular